With increasing economic demands, it is becoming progressively more important to gain additional information on drug candidates early in the development cycle. Better informed decision can be made during the selection of candidates if further solid state information is available – saving time and money later on in the development process. But early stage drug candidates are difficult and expensive to produce and often only a single gram of materials is available. To fulfill the challenge to learn more on these small amounts of compound, the crystallization expert, Technobis technologies represented by Nikyang developed the Crystalline family to provide a high throughput solution for crystallization research which plays a vital role throughout the various stages of drug development life cycle, from preclinical screening to process optimization.